Women’s empowerment is often spoken about, but real change is seen in those who break barriers and carve a niche for themselves despite cha ...

Indian equity indices ended strong on Friday, with the NIFTY closing at 23,350.40, up 159.75 points (0.69%), while the Sensex ...

Global pharma major Lupin Limited (Lupin) today announced that it has been awarded "Silver Medal" by EcoVadis for its ...

Amifampridine tablets are indicated for the treatment of Lambert-Eaton myasthenic syndrome in adults and pediatric patients 6 ...

Lupin Limited today announced that it has received tentative approval from the United States Food and Drug Administration for ...

The approval allows Lupin to enter the market for LEMS, rare autoimmune neuromuscular disorder affecting communication ...

On Monday, 1608 stocks advanced, 2503 declined and 130 remained unchanged on Bombay Stock Exchange with advance decline ratio ...

Lupin has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Amifampridine Tablets, 10 mg. This product would be ...

Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food ...

This approval positions Lupin to tap into a substantial market opportunity for a drug indicated for the treatment of ...

Goa transforms how you build APIs and microservices in Go with its powerful design-first approach. Instead of writing boilerplate code, you express your API's intent through a clear, expressive DSL.

Drug firm Lupin Ltd on Friday (March 7) said it has launched rivaroxaban tablets USP, 2.5 mg, in the US market following final approval from the US Food and Drug Administration (FDA) for its ...